Corrigendum to “FGF/FGFR inhibitors downmodulate c-Myc oncoprotein and hamper the growth of adrenocortical carcinoma” [Biomed. Pharmacother. 192 (2025) 118677] - 23/11/25

Sara Taranto ^{a, b,} 1

  Co-first authors.

, Jessica Faletti ^a, 1

  Co-first authors.

, Mariangela Tamburello ^a, Roberto Ronca ^{a, c}, Giulia Garattini ^a, Giorgia Gazzaroli ^a, Marta Turati ^a, Edoardo Rocca ^d, Riccardo Castelli ^d, Andrea Abate ^a, Luca Mignani ^a, Marta Laganà ^e, Constanze Hantel ^{f, g}, Sandra Sigala ^a, Marco Presta ^a, Arianna Giacomini ^{a, ⁎}

^a Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy 

^b Clinical Trial Center, Translational Research and Phase I Unit, ASST Spedali Civili di Brescia, Brescia, Italy 

^c Consorzio Interuniversitario per le Biotecnologie (CIB), Italy 

^d Department of Food and Drug, University of Parma, Parma, Italy 

^e Medical Oncology Department, ASST Spedali Civili of Brescia, Brescia, Italy 

^f Department of Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich (USZ) and University of Zurich (UZH), Zürich, Switzerland 

^g Medizinische Klinik und Poliklinik III, University Hospital Carl Gustav Carus Dresden, Dresden, Germany 

^⁎Corresponding author.

Il testo completo di questo articolo è disponibile in PDF.